NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/20/2023
Back to search
Official data from USPTO
EPL ACLAIRO PHARMACEUTICAL DEVELOPMENT GROUP, INC. AN EPL COMPANY DISCOVER THE BEST SCIENCE CAN OFFER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
06/20/2023
Trademark type
Combined
Nice classes
42
Filing date
04/05/2022
Registration date
06/20/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/20/2023
Last transaction
06/20/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2021-06-00
First use in commerce
2021-06-00
Drawing code
3
Owner type
03
Owner location
Sterling, VA, US
Examiner
BLAKESLEE, RICHARD A
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "EPL" to the right of a stylized design of a partial microscope contained within a rectangle with rounded corners. The wording "EPL" is contained within an incomplete circle, which is interlinked with another incomplete circle on the right. The incomplete circle on the right surrounds the stylized wording "ACLAIRO PHARMACEUTICAL DEVELOPMENT GROUP, INC. AN EPL COMPANY" and an incomplete oblong oval. Below is the stylized wording "DISCOVER THE BEST SCIENCE CAN OFFER".
Holders and representatives
Holders
Experimental Pathology Laboratories, Inc.
Representatives
DANIEL R. GROPPER REES, BROOME PC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Consultation on biomedical research in the fields of pharmaceuticalspharmaceutical biologicsmedical deviceshistologypathologytoxicology; consultation on scientific analysis in the fields of pharmaceuticalspharmaceutical biologicsmedical deviceshistologypathologytoxicologyall relating to biomedical science; product development consultation in the fields of pharmaceuticalspharmaceutical biologicsmedical deviceshistologypathologytoxicologyall for use in biomedicine
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/15/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/21/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/26/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/26/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/26/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/26/2023
DOCK
ASSIGNED TO EXAMINER
01/23/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2022
NWAP
NEW APPLICATION ENTERED
04/08/2022
Continuous trademark protection
Get notified about every new filing that threatens EPL ACLAIRO PHARMACEUTICAL DEVELOPMENT GROUP, INC. AN EPL COMPANY DISCOVER THE BEST SCIENCE CAN OFFER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.